Mesenchymal Stem Cells Derived from Human Chorionic Plate May Promote Hematopoietic Differentiation of the Human Embryonic Stem Cell Line SNUhES3

S. Kim,J. Yoo,B. Kim,J. Oh,C. Song,Hye-Jin Shin,Sun Haeng Kim,C. Choi,Jun Suk Kim

DOI: https://doi.org/10.1159/000094687

2006-10-01

Acta Haematologica

Abstract:entiation. The SNUhES3, which was established by the Seoul National University and recently described [6] , was used, and the institutional review board of the Korea University Medical Center approved this study protocol. We obtained human placentas from two healthy pregnant women during normal full-term delivery after written informed consent. hCP membranes were separated from the placenta, and the cells were isolated from hCP by enzyme digestion. The isolated cells were cultured in DMEM with 20% FBS and antibiotics, and MSCs were obtained by enzyme digestion from them. Embryoid bodies (EBs) were formed from SNUhES3 in the culture medium for EB formation (DMEM/F-12, 20% SR, without basic fibroblast growth factor). EBs were co-cultured with MSCs from hCP in the culture medium composed of Iscove’s modified Dulbecco’s medium (Invitrogen Corp., Carlsbad, Calif., USA) with 12.5% FBS, 12.5% horse serum, L -glutamine and 1% penicillin during 21 days. Five, 7, 10, 14 and 21 days after the start of co-culture, the cells were harvested, transformed into single cell suspensions and analyzed by flow cytometry with CD34-FITC and CD38-PE monoclonal antibodies (Beckman Coulter, Fullerton, Calif., USA) and colony-forming cell assays. As a control, hES cells not transformed into EBs were co-cultured with MSCs and analyzed in the same way. We perHematopoietic stem cells (HSCs) have been utilized to treat patients with incurable hematologic disorders. However, the limitation of sources for HSCs has restricted their clinical application. Thus human embryonic stem (hES) cells have been investigated as an alternative source of HSCs because they have the capacity to differentiate into multiple tissue lineages [1–3] . However, the optimal methods for hematopoietic differentiation from hES cells have not been clearly defined. In our previous study we co-cultured an hES cell line, SNUhES3, with human bone marrow stromal cells and suggested that mesenchymal stem cells (MSCs) derived from human bone marrow might play a role in inducing hematopoietic differentiation of hES cells [4] . However, it is not easy to obtain human bone marrow stromal cells because this is possible only during the harvest of bone marrow stem cells from healthy donors for stem cell transplantation. Thus it is inevitable to find a source providing enough MSCs for co-culture with hES cells. Recently the chorionic plate of the human placenta has been presented as a source of MSCs similar to those from human bone marrow [5] . However, there has been no report using human chorionic plate (hCP) for the hematopoietic differentiation of hES cells. Therefore we have tried to co-culture an hES cell line, SNUhES3, with MSCs derived from hCP to induce hematopoietic differReceived: January 3, 2006 Accepted after revision: February 15, 2006